Phase 2 of Sero Survey Begins in Latehar, Simdega, Pakur Survey GHDx Entry last modified on: Feb 10, 2022
Anti-SARS-CoV-2 IgG antibodies in adolescent students and their teachers in Saxony, Germany (SchoolCoviDD19): very low seropraevalence and transmission rates. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Increase in SARS-CoV-2 seroprevalence in healthy blood donors after the second wave of COVID-19 pandemic in South-Eastern Italy: evidence for asymptomatic young individuals as potential virus spreaders. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020 Scientific literature GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of Specific Antibodies against SARS-CoV-2 from Hotspot Communities in the Dominican Republic Scientific literature GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors Scientific literature GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies: Results from a population-based study in Bonn, Germany. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
COVID-19 at a metropolitan region: public polices and social vulnerability within an iniquity context. Preprint COVID-19 em uma Região Metropolitana: vulnerabilidade social e políticas públicas em contextos de desigualdades Scientific literature GHDx Entry last modified on: Mar 14, 2022
Spain - National Study of Sero-epidemiology of Infection by Sars-Cov-2 2020 Estudio Nacional de Sero-epidemiología de la Infección por Sars-Cov-2 en España Survey: Exam - Household - Interview - Longitudinal GHDx Entry last modified on: Aug 24, 2023
Estonia COVID-19 Coronavirus prevalence study 2020-2023 Koroonaviiruse levimuse uuring "Covid-19 aktiivne seire" Survey: Epi surveillance GHDx Entry last modified on: Aug 28, 2023
Strategies for Infection Control and Prevalence of Anti-SARS-CoV-2 IgG Antibodies in 4,554 Employees of a University Hospital in Munich, Germany. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
CDC COVID Data Tracker Commercial Laboratory Seroprevalence Survey Data 2020-2022 Survey: Epi surveillance - Individual - Subnationally representative GHDx Entry last modified on: Aug 24, 2023
Canada COVID-19 Seroprevalence Report - April 2020 to January 2021 COVID-19 Public Seroprevalence Report April 2020 to January 2021 Epi surveillance: Nationally representative GHDx Entry last modified on: Aug 2, 2022
Sero-prevalence of anti-SARS-CoV-2 Antibodies in Addis Ababa, Ethiopia. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Denmark Blood Donors are Now Being Re-examined for Coronavirus Infection Survey: Epi surveillance GHDx Entry last modified on: May 12, 2022
England - Coronavirus (COVID-19) Infection Survey: Antibody Data, January 2021 Coronavirus (COVID-19) Infection Survey: antibody data for the UK, January 2021 Survey: Epi surveillance GHDx Entry last modified on: May 12, 2022
A COVID-19 Hotspot Area: Activities and Epidemiological Findings Scientific literature GHDx Entry last modified on: Mar 14, 2022
Canada - COVID-19 Data in Quebec 2020 Données COVID-19 au Québec Epi surveillance GHDx Entry last modified on: Aug 1, 2022
Seroprevalence of COVID-19 virus infection in Guilan province, Iran. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Scotland Enhanced Surveillance of Covid-19 Dashboard 2020-2022 Enhanced Surveillance of Covid-19 in Scotland (Population-based seroprevalence) Epi surveillance: Epi surveillance GHDx Entry last modified on: Aug 24, 2023
Prevalence of SARS-CoV-2 Antibodies from a one-year National Serosurveillance of Kenyan Blood Transfusion Donors. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Brazil - Rio Grande Do Sol Epicovid19 Relevance Study 2020 Survey: Epi surveillance GHDx Entry last modified on: Aug 1, 2022
Canada COVID-19 Seroprevalence Report - January 12, 2021 COVID-19 Seroprevalence Report January 12, 2021 - Report #4: November 2020 Survey Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Canada COVID-19 Seroprevalence Report - December 18, 2020 COVID-19 Seroprevalence Report December 18, 2020 - Report #3: October 2020 Survey Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Detection of Antibodies After Review of Covid-19 in Blood Donors (Sub-report 2) Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 2) Survey: Epi surveillance GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020 Scientific literature GHDx Entry last modified on: Mar 14, 2022
Germany - Saarland antibody study on coronavirus infection completed: Institute for Virology at Saarland University Hospital presents results Epi surveillance GHDx Entry last modified on: Feb 10, 2022
Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020 Scientific literature GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline Scientific literature GHDx Entry last modified on: May 12, 2022
France Covid-19 Information - Average number of new daily hospitalizations 2020-2022 Informations Covid-19 - Nombre moyen de nouvelles hospitalisations quotidiennes Epi surveillance GHDx Entry last modified on: Aug 24, 2023
Brazil - Government of Espírito Santo COVID-19 Serological Survey 2020 Coronavírus - Inquérito Sorológico Survey GHDx Entry last modified on: Aug 29, 2023
France COVID-19 Epidemic Monitoring Dashboard 2020-2022 Tableau de bord COVID-19 Suivi de l’épidémie de COVID-19 en France Epi surveillance GHDx Entry last modified on: Aug 24, 2023
Belgium Prevalence of anti-SARS-CoV-2 antibodies (IgG) among blood donors 2020-2021 Belgium COVID-19 Studies, Seroprevalence in Blood Donors Epi surveillance GHDx Entry last modified on: Aug 24, 2023
United States - COVID-19 Diagnostic Laboratory Testing (PCR Testing) Time Series 2020-2022 Epi surveillance: Health facility - Subnationally representative GHDx Entry last modified on: Aug 24, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among Adults in a Tropical City of the Caribbean Area, Colombia: Are We Much Closer to Herd Immunity Than Developed Countries? Scientific literature GHDx Entry last modified on: Mar 14, 2022
India COVID-19 Official Government of India updates - Twitter 2020-2022 Epi surveillance GHDx Entry last modified on: Aug 28, 2023
Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study Scientific literature GHDx Entry last modified on: Mar 14, 2022
Switzerland COVID-19 PCR Antigen Tests by Region 2020 Daily record timelines by geoRegion and test type (pcr/antigen) for testsonen Epi surveillance: Subnationally representative GHDx Entry last modified on: May 12, 2022
Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020 Scientific literature GHDx Entry last modified on: Jan 31, 2024
Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India Scientific literature GHDx Entry last modified on: Jan 31, 2024
Dynamics of seroconversion of anti-SARS-CoV-2 IgG antibodies in the Czech unvaccinated population: nationwide prospective seroconversion (PROSECO) study. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China Scientific literature GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 significantly varies with age: Preliminary results from a mass population screening Scientific literature GHDx Entry last modified on: Jun 17, 2021
Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Results of a Population-Based Survey to Estimate the Seroprevalence of SARS-CoV-2 Specific IgG Antibodies in Kashmir, India, Seven Months after the Appearance of the First COVID-19 Case. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Canada - Daily Epidemiologic Summary of COVID-19 in Ontario 2020 Epidemiologic Summary COVID-19 in Ontario Epi surveillance GHDx Entry last modified on: May 12, 2022
A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms. Preprint Scientific literature GHDx Entry last modified on: Jun 18, 2021
Seroprevalence of SARS-CoV-2 IgG antibodies in two regions of Estonia (KoroSero-EST-1) Scientific literature GHDx Entry last modified on: Jun 17, 2021
SARS-CoV-2 Seroprevalence in Tamil Nadu in October-November 2020. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022